Physician profile
Julia Jensen
NPI 1003819509
$598.97
in general payments reported to CMS, 2019-2025
16 companies · $77.50 in 2025
The $77.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.69 · 2020: $26.46 · 2021: $103 · 2022: $200 · 2023: $127 · 2024: $20.26 · 2025: $77.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $111.20 | 2020-2022 | |
| Foundation Medicine, INC. | $91.54 | 2023 | |
| Abbvie INC. | $80.39 | 2021-2024 | |
| Amarin Pharma, INC. | $44.69 | 2019 | |
| Novo Nordisk INC | $42.58 | 2025 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $34.92 | 2025 | The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $28.00 | 2022 | |
| Glaxosmithkline, LLC. | $27.05 | 2021-2023 | Arexvy |
| Ibsa Pharma INC. | $21.91 | 2021 | |
| Eisai INC. | $18.51 | 2021 | |
| Merck Sharp & Dohme LLC | $18.29 | 2022 | |
| Lilly USA, LLC | $18.06 | 2022 | |
| Lundbeck LLC | $17.90 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.50 | 2021 | |
| Adlon Therapeutics L.P. | $15.15 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.